CHEM 342 - Introduction to Biochemistry

Hemoglobinopathy Assignment - Due 10 May 2002

Linus Pauling introduced the concept of molecular disease by demonstrating that the gene for sickle cell anemia was directly related to a chemical alteration of hemoglobin in the red blood cells of affected individuals. A few years later, Vernon Ingram identified a single amino acid replacement at position 6 of the beta chains of sickle cell hemoglobin (HbS) and showed that the sequence of the remaining 145 amino acids of the beta chains and all 141 amino acids in the alpha chains of hemoglobin were unchanged compared to normal hemoglobin (HbA). Subsequently, others determined the exact nucleotide substitution mutation in the beta globin gene possessed by sickle cell patients.

These discoveries prompted a stampede of sorts to discover other hemoglobin variants and the corresponding mutations in DNA. There are now on the order of 1000 different mutations known to affect the amino acid sequence or production of hemoglobin. While most of these are single-base-substitution mutations; deletions, insertions, and regulatory mutations are known. The consequences vary from benign to severe, as in the case of thalassemias. Many medical biochemists have made a career studying these usually rare hemoglobinopathies.

Using a list of hemoglobinopathies (alpha-chain, beta-chain, thalassemias), pick an interesting example to investigate as the basis for a 5+ page, double-spaced, well-organized report. Select a variant that no one else in class has selected. Your report should have the following elements:

This assignment will be evaluated for its composition, content, clarity of presentation, and depth of your analysis. An "A paper" must go beyond simple reporting of information.  For example, a molecular graphics representation of your hemoglobin variant showing the location of any mutational modification. Remember, this should be your synthesis of the information, not a paraphrasing of the words of others. Late papers will not be accepted.

Suggestion: Because there are many inconsequential hemoglobin variants that are hardly worth writing about, it is important to have a strategy for identifying interesting variants. As with any database search, it is useful to think of clever ways to search to maximize desirable results. Here is a suggestion for a productive strategy. Nobel Prize winner, Max Perutz (1914-2002), spent 20 years working on the X-ray crystallography of hemoglobin before he finally determined its three-dimentional structure in 1957. There after he spent much of the rest of his life studying the structure of interesting hemoglobin variants. One strategy you might try is to search and examine the publications of Max Perutz on PubMed or the Web of Science. Remember, you can often get full text copies through the University of Delaware's electronic journal subscriptions. You may also find some of the sites linked to the course home page of use.



Return to Hal White's Home Page, Course Home Page, or Departmental Home Page.
Last updated: 6 April 2002 by Hal White
Copyright 2002, Harold B. White, Department of Chemistry and Biochemistry, University of Delaware